Multiple myeloma expressing CD19+CD56− phenotype
✍ Scribed by Naohi Sahara; Michio Ihara; Takaaki Ono; Sadahiro Tamashima; Hirotaka Matsui; Akihiro Takeshita; Ryuzo Ohno
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 101 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract CD66a is a member of the carcinoembryonic antigen family and has been suggested to function as an intercellular adhesion molecule and cell growth regulator. Expression of CD66a in myeloma cells was examined with mAb TS135 against CD66a transfectants of murine‐transformed fibroblasts. Th
Background: Even modern automatic cell counters cannot count basophils precisely. Therefore, we need a rapid, accurate, precise, and easy method for counting basophils. Methods: Using flow cytometry, basophils (CD22ϩ/CD19-) and B cells (CD22ϩ/CD19ϩ) were counted. Within a large lymphocyte light scat
## BACKGROUND. CD56 antigen or NCAM (neural cell adhesion molecule) has an established role in the diagnosis of non-Hodgkin lymphoma (NHL)-natural killer cell type and other hematologic malignancies. Therefore, it is included routinely in the panel of antibodies for flow cytometric (FC) analysis o